PMID- 6140821
OWN - NLM
STAT- MEDLINE
DCOM- 19840214
LR  - 20121115
IS  - 0300-8967 (Print)
IS  - 0300-8967 (Linking)
VI  - 83
IP  - 4
DP  - 1983 Jul-Aug
TI  - Teflutixol (Lu 10-022): a new thioxanthene derivative with antipsychotic 
      properties. A pilot study.
PG  - 397-406
AB  - A new thioxanthene derivative, teflutixol (Lu 10-022) has been administered for 4 
      weeks to 21 patients [12 schizophrenics, 6 patients with obsessive, compulsive 
      neurosis (OCN), 2 patients with affective psychosis (AP), and one patient with 
      paranoic reactions (PR)]. The maximum daily dose varied between 0.5 mg and 4 mg 
      administered once in the morning. Fifteen of the patients received 1 mg or less 
      daily. Based upon weekly assessments by the BPRS as well as a global evaluation 
      all 4 groups showed a clear amelioration of the scores, and for both the 
      schizophrenics and the patients with OCN this was highly significant [student's t 
      (p less than 0.001)].
FAU - Botte, L
AU  - Botte L
LA  - eng
PT  - Journal Article
PL  - Belgium
TA  - Acta Psychiatr Belg
JT  - Acta psychiatrica Belgica
JID - 0247037
RN  - 0 (Antipsychotic Agents)
RN  - 0 (Thioxanthenes)
RN  - 1O8A15G935 (teflutixol)
SB  - IM
MH  - Adult
MH  - Antipsychotic Agents/*administration & dosage
MH  - Drug Evaluation
MH  - Female
MH  - Humans
MH  - Male
MH  - Mental Disorders/*drug therapy
MH  - Middle Aged
MH  - Obsessive-Compulsive Disorder/drug therapy
MH  - Schizophrenia/drug therapy
MH  - Thioxanthenes/*administration & dosage
EDAT- 1983/07/01 00:00
MHDA- 1983/07/01 00:01
CRDT- 1983/07/01 00:00
PHST- 1983/07/01 00:00 [pubmed]
PHST- 1983/07/01 00:01 [medline]
PHST- 1983/07/01 00:00 [entrez]
PST - ppublish
SO  - Acta Psychiatr Belg. 1983 Jul-Aug;83(4):397-406.